innovation for industry
The problem with implantable medical monitoring devices for organs like the eye, brain, or heart, is that the power sources are often larger than the actual sensors.
Startup Injectpower was founded in early 2020 to tackle this challenge. The company is building on a technology protected by 40 CEA-Liten and CEA-Leti patents to offer rechargeable millimeter-sized microbatteries. These tiny batteries make on-demand, intervention-free, in situ measurement possible.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.